Menu

Carisma Therapeutics, Inc. CARM

Full chart Compare
Set alert

Price alert · CARM

All alert types
0.00 USD 0.00 (+0.00%)

At closeNov 5, 2026, 4:00 PM EST

0.12 +0.12 +23,520.00%

After hours · Nov 5, 4:00 PM ET

0.0263 Day range 0.0324
0.0001 52-week range 0.10
YTD
-98.84%
1 year
-98.94%

Revenue & Expenses

Other Income → Expenses: $1.70MExpenses → Gross Loss: $40.04MExpenses → Selling, General & Admin: $20.14MExpenses → Research & Development: $59.67MOther Operating Income → Expenses: $57.67MNet Loss → Expenses: $60.48MRevenue → Cost of Revenue: $19.63MOther Income$1.70MOther Operating Income$57.67MNet Loss$60.48MCost of Revenue$59.67MExpenses$119.85MGross Loss$40.04MSelling, General & Admin$20.14MResearch & Development$59.67MRevenue$19.63M

Latest period ending Dec 31, 2024 · select a line to chart its full history

CARM annual income statement
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
19.63M14.92M9.83M26.54M11.24M
19.63M14.92M9.83M26.54M11.24M
-62.18M-88.73M-56.16M-65.39M-32.26M
-60.48M-86.88M-61.23M-336.00K-22.40M
-1.46-2.59-28.77—-3.80
CARM annual balance sheet
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
17.91M77.61M24.19M162.64M55.39M
30.46M89.55M72.15M240.75M122.82M
58.37M63.02M107.02M69.04M132.05M
2.48M3.12M40.16M00
-27.91M26.53M-157.06M171.71M-9.23M
CARM annual cash flow
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
-59.92M-81.18M-5.12M-68.88M-30.84M
-123.00K72.41M-32.56M-4.00K-8.00K
344.00K62.18M33.32M176.13M38.11M
-123.00K-1.13M-4.66M-4.00K-8.00K
-59.70M53.41M-4.36M107.25M7.27M